Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Company News

Miikana in-licenses Roche cancer compound

May 4, 2005 12:47 AM UTC

Roche (SWX:ROCZ) granted Miikana (Fremont, Calif.) exclusive global development and commercialization rights in all indications to MKC-1, a small molecule that arrests mitosis by inhibiting an undiscl...